Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Medikaloka Hermina Tbk's EBIT per Share for the
three
months ended in Jun. 2026 was Rp14.48.
Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2026 was Rp61.97.
During the past 12 months, the average EBIT per Share Growth Rate of PT Medikaloka Hermina Tbk was 1.00% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 21.00% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -3.80% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 15.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for PT Medikaloka Hermina Tbk's EBIT per Share or its related term are showing as below:
ISX:HEAL'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -15.6 Med: 17.65 Max: 67.1
Current: 21
During the past 11 years, the highest 3-Year average EBIT per Share Growth Rate of PT Medikaloka Hermina Tbk was 67.10% per year. The lowest was -15.60% per year. And the median was 17.65% per year.
ISX:HEAL's 3-Year EBIT Growth Rate is ranked better than 62.72% of 523
companies
in the Healthcare Providers & Services industry
Industry Median: 12
vs ISX:HEAL: 21.00
PT Medikaloka Hermina Tbk (ISX:HEAL) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
PT Medikaloka Hermina Tbk EBIT per Share Related Terms
PT Medikaloka Hermina Tbk EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp61.97
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Medikaloka Hermina Tbk (ISX:HEAL) has a EBIT per Share of Rp61.97 as of Jun. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on PT Medikaloka Hermina Tbk and its competitors. According to the industry distribution chart, PT Medikaloka Hermina Tbk ranks #195 out of 523 companies in the Healthcare Providers & Services industry, placing it in the top 37.3%.
Is PT Medikaloka Hermina Tbk's EBIT per Share too high?
PT Medikaloka Hermina Tbk's current EBIT per Share is Rp61.97. Based on the distribution chart, PT Medikaloka Hermina Tbk ranks #195 out of 523 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, PT Medikaloka Hermina Tbk has a GF Score™ of 68/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Medikaloka Hermina Tbk's EBIT per Share compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Medikaloka Hermina Tbk ranks #195 out of 523 companies for EBIT per Share. This puts PT Medikaloka Hermina Tbk in the upper half of its industry. The industry median EBIT per Share is 12.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 12.00, based on 523 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on PT Medikaloka Hermina Tbk and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 12.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Medikaloka Hermina Tbk's current EBIT per Share is Rp61.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Medikaloka Hermina Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk (ISX:HEAL) is currently considered Significantly Undervalued. The stock's GF Value™ is Rp1,554.15, compared to a current price of Rp795.00 — trading 48.8% below its estimated fair value. The current EBIT per Share is Rp61.97. PT Medikaloka Hermina Tbk's overall GF Score™ is 68/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For PT Medikaloka Hermina Tbk (ISX:HEAL), the current EBIT per Share is Rp61.97 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Medikaloka Hermina Tbk (ISX:HEAL) Overvalued in 2026?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk stock appears to be undervalued.
The current stock price of Rp795.00 is trading 48.8% below its estimated GF Value™ of Rp1,554.15.
GuruFocus considers PT Medikaloka Hermina Tbk to be Significantly Undervalued.
Key valuation signals for ISX:HEAL:
EBIT per Share: Rp61.97
GF Value™: Rp1,554.15 vs. price of Rp795.00 (48.8% below fair value)
No single metric tells the full story. See the ISX:HEAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Medikaloka Hermina Tbk is a private hospital group. It provides a range of medical services, including maternal and child health services, complex operating procedures, laboratory services, radiology facilities, and fertility treatments as well as general health services, pharmacies, diagnostic and emergency services. The company's geographical segment includes Kalimantan dan Sulawesi, Jawa, and Sumatera. It derives maximum revenue from the Jawa segment.
68GF Score
Get the complete analysis for ISX:HEAL
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:HEAL has been successfully added to your 
